Daphne Karydas

MLYS

Daphne Karydas serves as Director at Mineralys Therapeutics, Inc. (MLYS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$689.8K

Net Position

Net Seller

$689.8K

Companies Traded

MLYS

Active Period

Nov 2025

1 total trades

Most Recent

Sell MLYS

Nov 13, 2025 · $689.8K

Daphne Karydas's Insider Trading at Mineralys Therapeutics, Inc. (MLYS)

Buys

0 · $0.00

Sells

1 · $689.8K

Total Shares Bought

Total Shares Sold

15,000

MLYS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 13, 2025↗	Sell	15,000	$45.99	$689.8K	4,885

Related Insiders

David Malcom Rodman

officer: Chief Medical Officer

MLYSSell · Mar 17, 2026

David Malcom Rodman

Chief Medical Officer

MLYSSell · Feb 17, 2026

Adam Scott Levy

officer: CFO and Secretary

MLYSSell · Jan 13, 2026

Jon Congleton

director, officer: Chief Executive Officer

MLYSSell · Jan 13, 2026

Brian Taylor Slingsby

Director

MLYSSell · Nov 21, 2025

Adam Scott Levy

CFO and Secretary

MLYSSell · Nov 13, 2025

Alexander M Gold

Director

MLYSSell · Nov 13, 2025

Jon Congleton

Chief Executive Officer

MLYSSell · Nov 13, 2025

Explore More Insider Trading Data

MLYS Insider Trading Activity

View all insider trades at Mineralys Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity